Yatırımcı.AI

BISTTRY14:24Live

Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş.

Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş.GENIL

Star MarketChemicals, Petroleum, Rubber and Plastics
6.73−0.62 (−8.44%)
Volume
TRY 177.7M
Day range
6.64 – 7.18
Previous close
7.35
Market cap
TRY 30.3B

Net Profit

Sales

Quarterly Sales

Equity

EBITDA

Quarterly EBITDA

Total Assets

Total Liabilities

Frequently Asked Questions

Quarterly, annualised and cumulative sales, EBITDA, net profit, assets, liabilities and equity series for Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GENIL), derived from KAP financial reports. Amounts are in TRY.

In the latest period (2025/6) GENIL reported a net profit of TRY 132.1M, sales of TRY 6B and EBITDA of TRY 640.6M.

Annualised values sum the last four quarters, giving a seasonally neutral twelve-month figure used in ratios such as P/E and EV/EBITDA.